(Q37777458)

23 August 2017

1 reference

title

The revitalized tau hypothesis on Alzheimer's disease (English)

1 reference

23 August 2017

The Revitalized Tau Hypothesis on Alzheimer's Disease (English)

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2010.03.007

16 June 2024

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20682182

16 June 2024

2

Gonzalo Farías

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20682182

16 June 2024

author name string

Inelia Morales

3

1 reference

23 August 2017

Leonardo Navarrete

4

1 reference

23 August 2017

Ricardo B. Maccioni

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20682182

16 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20682182

16 June 2024

publication date

1 April 2010

1 reference

full work available at URL

23 August 2017

https://api.elsevier.com/content/article/PII:S0188440910000500?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2010.03.007

https://api.elsevier.com/content/article/PII:S0188440910000500?httpAccept=text/plain

16 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2010.03.007

Archives of Medical Research

16 June 2024

published in

1 reference

23 August 2017

volume

41

1 reference

23 August 2017

issue

3

1 reference

23 August 2017

page(s)

226-231

1 reference

The molecular bases of Alzheimer's disease and other neurodegenerative disorders

23 August 2017

cites work

3

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2010.03.007

Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease

16 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2010.03.007

Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology

16 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2010.03.007

Role of microtubule-associated proteins in the control of microtubule assembly

16 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2010.03.007

Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease

16 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2010.03.007

The damage signals hypothesis of Alzheimer's disease pathogenesis.

16 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2010.03.007

The role of neuroimmunomodulation in Alzheimer's disease.

16 June 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2010.03.007

A discrete repeated sequence defines a tubulin binding domain on microtubule-associated protein tau.

16 June 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2010.03.007

Immunological characterization of epitopes on tau of Alzheimer's type and chemically modified tau.

16 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2010.03.007

Tau conformational changes correspond to impairments of episodic memory in mild cognitive impairment and Alzheimer's disease.

16 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2010.03.007

Anomalously phosphorylated tau and Abeta fragments in the CSF correlates with cognitive impairment in MCI subjects

16 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2010.03.007

Disaggregation of tau as a therapeutic approach to tauopathies

16 June 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2010.03.007

The widespread alteration of neurites in Alzheimer's disease may be unrelated to amyloid deposition

16 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2010.03.007

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

16 June 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2010.03.007

Biological markers of Alzheimer's disease and mild cognitive impairment

16 June 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2010.03.007

Neuroimmunomodulation in the pathogenesis of Alzheimer's disease

16 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2010.03.007

The natural and molecular history of Alzheimer's disease.

16 June 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2010.03.007

Accumulation of pathological tau species and memory loss in a conditional model of tauopathy.

16 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2010.03.007

Granular tau oligomers as intermediates of tau filaments

16 June 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2010.03.007

Increased levels of granular tau oligomers: an early sign of brain aging and Alzheimer's disease

16 June 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2010.03.007

In vitro assembly of tau protein: mapping the regions involved in filament formation

16 June 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2010.03.007

Structural impact of heparin binding to full-length Tau as studied by NMR spectroscopy

16 June 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2010.03.007

Highly populated turn conformations in natively unfolded tau protein identified from residual dipolar couplings and molecular simulation.

16 June 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2010.03.007

Assembly in vitro of tau protein and its implications in Alzheimer's disease.

16 June 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2010.03.007

The natively unfolded character of tau and its aggregation to Alzheimer-like paired helical filaments.

16 June 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2010.03.007

A Cdk5-p35 stable complex is involved in the beta-amyloid-induced deregulation of Cdk5 activity in hippocampal neurons

16 June 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2010.03.007

AbetaPP induces cdk5-dependent tau hyperphosphorylation in transgenic mice Tg2576.

16 June 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2010.03.007

Oxidative stress promotes tau dephosphorylation in neuronal cells: the roles of cdk5 and PP1.

16 June 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2010.03.007

Mild cognitive impairment and Alzheimer patients display different levels of redox-active CSF iron

16 June 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2010.03.007

Insulin resistance and Alzheimer's disease: molecular links & clinical implications.

16 June 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2010.03.007

Neuroprotective effect of TNFalpha against the beta-amyloid neurotoxicity mediated by CDK5 kinase.

16 June 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2010.03.007

Inflammatory aspects of Alzheimer disease and other neurodegenerative disorders

16 June 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2010.03.007

Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway.

16 June 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2010.03.007

Production of nerve growth factor by beta-amyloid-stimulated astrocytes induces p75NTR-dependent tau hyperphosphorylation in cultured hippocampal neurons.

16 June 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2010.03.007

Crosstalk between calcium, amyloid beta and the receptor for advanced glycation endproducts in Alzheimer's disease

16 June 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2010.03.007

The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.

16 June 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2010.03.007

Roles of heat-shock protein 90 in maintaining and facilitating the neurodegenerative phenotype in tauopathies

16 June 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2010.03.007

Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo

16 June 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2010.03.007

An inhibitor of tau hyperphosphorylation prevents severe motor impairments in tau transgenic mice

16 June 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2010.03.007

Methylene blue and Alzheimer's disease.

16 June 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2010.03.007

Anthraquinones inhibit tau aggregation and dissolve Alzheimer's paired helical filaments in vitro and in cells

16 June 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2010.03.007

Selective interaction of lansoprazole and astemizole with tau polymers: potential new clinical use in diagnosis of Alzheimer's disease

16 June 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2010.03.007

16 June 2024

Identifiers

1 reference

23 August 2017

1 reference